HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0
Hologic upholds its focus on equity with new research findings on its Breast Imaging AI solution.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?
HOLX will unveil breakthrough innovations at this year's RSNA, focusing on imaging solutions and AI.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Retain Hologic Stock in Your Portfolio Now?
HOLX's strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?
Despite the recent earnings miss, Hologic's portfolio strength and capital allocation strategy can be appealing to investors.
Hologic Q4 Earnings Lag, Revenues Top, Stock Down in Aftermarket
HOLX's fiscal 2024 fourth-quarter results underscore the durable growth of its businesses.
Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript
Hologic, Inc. (NASDAQ:HOLX ) Q4 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President & Chief Executive Officer Essex Mitchell - Chief Operating Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Anthony Petrone - Mizuho Group Vijay Kumar - Evercore ISI Casey Woodring - JPMorgan Mike Matson - Needham & Company Navann Ty - BNP Paribas Ricardo Moreno - RBC Capital Markets Maggie Wilmouth - William Blair Andrew Cooper - Raymond James Operator Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today's call.
Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hologic (HOLX) Q4 Earnings Miss Estimates
Hologic (HOLX) came out with quarterly earnings of $1.01 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.89 per share a year ago.
Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Hologic (HOLX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
